Key points are not available for this paper at this time.
Our improved understanding of the clinical onset, progression, neuroimaging, pathologic features, genetics, and other risk factors for AD impacts the approaches to clinical diagnosis and future therapeutic interventions.
Liana G. Apostolova (Fri,) studied this question.